Clinical Trials Directory

Trials / Completed

CompletedNCT04765852

Growth, Safety and Efficacy of a Probiotic Supplement

Growth, Safety and Efficacy of a Probiotic Supplement: a Double-blind, Randomized, Placebo-controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
228 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
14 Days – 21 Days
Healthy volunteers
Accepted

Summary

The primary objective of the study is to demonstrate the safety of a daily high dose of a probiotic supplement by comparing the growth (weight gain, g/day) of formula-fed and/or breastfed infants in high dose group versus placebo group from enrolment to 8 weeks of intervention

Detailed description

This is a randomized, placebo-controlled, double-blind study of healthy term infants, consisting of three randomized arms: placebo control group, high dose experimental group, and low dose experimental group. The study population, approximately 228, are infants 14 - 21 days of age who are formula-fed and/or breastfed who is aligned with the intended target population for a probiotic supplement. Placebo and probiotic supplements will be mixed with formula or breastmilk and fed orally using a feeding cup or syringe. All enrolled infants will participate in the trial for approximately 8 weeks.

Conditions

Interventions

TypeNameDescription
OTHERHigh dose probiotic supplementOne probiotic stick pack will be dissolved in 10 mL lukewarm formula milk or breastmilk at body temperature. The dissolved supplement will be fed orally, preferably in the morning, starting on Day 1 until Day 56.
OTHERLow dose probiotic supplementOne probiotic stick pack will be dissolved in 10 mL lukewarm formula milk or breastmilk at body temperature. The dissolved supplement will be fed orally, preferably in the morning, starting on Day 1 until Day 56.
OTHERPlaceboOne placebo stick pack will be dissolved in 10 mL lukewarm formula milk or breastmilk at body temperature. The dissolved supplement will be fed orally, preferably in the morning, starting on Day 1 until Day 56.

Timeline

Start date
2021-02-26
Primary completion
2021-08-23
Completion
2021-10-12
First posted
2021-02-23
Last updated
2023-03-24

Locations

1 site across 1 country: Philippines

Source: ClinicalTrials.gov record NCT04765852. Inclusion in this directory is not an endorsement.